Study Stopped
Lack of enrollment
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
ROM
Flexible Hydrogel Nanoparticle Wound Dressing Allows Greater Joint Range of Motion Compared to Typical Sodium Carboxymethylcellulose Dressing
1 other identifier
interventional
3
1 country
1
Brief Summary
The objective of this study is to evaluate the difference in joint range of motion of a new flexible hydrogel nanoparticle wound dressing compared to typical sodium carboxymethylcellulose dressing Aquacel AG for treatment of partial thickness burns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 2, 2010
CompletedFirst Posted
Study publicly available on registry
February 4, 2010
CompletedJune 8, 2011
June 1, 2011
1.4 years
February 2, 2010
June 7, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Range of motion in burned joints with dressing in place as compared to control
Up to 2 weeks
Secondary Outcomes (1)
Pain at joint with dressing in place
up to 2 weeks
Study Arms (2)
Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing
EXPERIMENTALNanoflex Powder Dressing applied to joint
Aquacel AG, typical carboxymethylcellulose dressing
ACTIVE COMPARATORSodium CMC dressing control applied to joint
Interventions
4" X 4", Aquacel silver sheet
Wound dressing
Eligibility Criteria
You may qualify if:
- Male or female patient is at least 2 years of age;
- Patient is in general good health;
- Patient has partial thickness burn that crosses at least one peripheral joint axial to the proximal interphalangeal joints;
- Patient has one unburned contralateral joint without major internal or external joint derangement to be used as control
- Patient is willing and able to cooperate with the protocol for 30 days
- Patient is capable of provided informed consent
- Patient provides authorization for use and disclosure of protected health information
You may not qualify if:
- Age less than 2 years;
- Patient has superficial or full thickness burn wounds;
- Patient has acutely infected wounds;
- Patient has wounds with surrounding cellulites;
- Patient has a history of hypersensitivity to any components of either the nanoparticle or sodium hydrocellulose dressing, or any know sensitivities to other hydrogel bandage treatments
- Patient has a concurrent clinical condition, which in the judgment of the Investigator cold either pose a health risk to the patient while participating in this study, or could potentially influence the outcome of the study;
- Patient is wearing any type of orthopedic device that may come in contact with the dressing;
- Patient has history of poor wound healing, history of smoking, history of drug/alcohol abuse, any other skin/immune system condition that would increase likelihood of wound irritation, infection or increase chance of early termination
- Patient has wound originating from chronic condition
- Patients with history of any immunodeficiency syndrome or condition
- Patients who have applied any dressing or medication (OTC or prescription) to the wound (within 48 hours of study? )
- Patient has participated in a clinical research study within the last 30 days prior to enrollment;
- Patient is unable to communicate or to cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ULURU Inc.lead
Study Sites (1)
UT Southwestern
Dallas, Texas, 75390, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 2, 2010
First Posted
February 4, 2010
Study Start
May 1, 2007
Primary Completion
October 1, 2008
Study Completion
October 1, 2008
Last Updated
June 8, 2011
Record last verified: 2011-06